Correlation Between Design Therapeutics and SOUTHERN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and SOUTHERN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and SOUTHERN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and SOUTHERN PER CORP, you can compare the effects of market volatilities on Design Therapeutics and SOUTHERN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of SOUTHERN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and SOUTHERN.

Diversification Opportunities for Design Therapeutics and SOUTHERN

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Design and SOUTHERN is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and SOUTHERN PER CORP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SOUTHERN PER P and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with SOUTHERN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SOUTHERN PER P has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and SOUTHERN go up and down completely randomly.

Pair Corralation between Design Therapeutics and SOUTHERN

Given the investment horizon of 90 days Design Therapeutics is expected to under-perform the SOUTHERN. In addition to that, Design Therapeutics is 7.0 times more volatile than SOUTHERN PER CORP. It trades about -0.05 of its total potential returns per unit of risk. SOUTHERN PER CORP is currently generating about 0.03 per unit of volatility. If you would invest  11,380  in SOUTHERN PER CORP on December 25, 2024 and sell it today you would earn a total of  145.00  from holding SOUTHERN PER CORP or generate 1.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy86.44%
ValuesDaily Returns

Design Therapeutics  vs.  SOUTHERN PER CORP

 Performance 
       Timeline  
Design Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Design Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
SOUTHERN PER P 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in SOUTHERN PER CORP are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, SOUTHERN is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Design Therapeutics and SOUTHERN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Design Therapeutics and SOUTHERN

The main advantage of trading using opposite Design Therapeutics and SOUTHERN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, SOUTHERN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SOUTHERN will offset losses from the drop in SOUTHERN's long position.
The idea behind Design Therapeutics and SOUTHERN PER CORP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated